Replies to post #119853 on Biotech Values

[DewDiligence]

3M and a British private-equity firm have been trading barbs publicly about a product that 3M decided not to commercialize. Here are the latest:

http://finance.yahoo.com/news/3M-Responds-to-Accusations-bw-3785196144.html?x=0&.v=1

http://finance.yahoo.com/news/Porton-Group-Slams-3Ms-prnews-447673034.html?x=0&.v=1

[DewDiligence]

This PR from 3M’s legal adversary has spin nonpareil:

http://finance.yahoo.com/news/3M-Forced-to-Pay-for-Breach-prnews-444513037.html?x=0&.v=3

From reading this PR, one might think that 3M was ordered to pay huge damages. In fact, the award was a scant $1.3M, about 2% of what the plaintiffs were seeking.